News & Events

News

All categories

Earnings

Press Release

All years

2021

2020

2019

2018

2017

2016

2015

2014

Affimed Announces Addition of Dr. Andrew Evens to Scientific Advisory Board

January 14, 2016

Affimed to Present at Noble Financial Capital Markets’ 12th Annual Investor Conference

January 12, 2016

Affimed Added to NASDAQ Biotech Index®

December 14, 2015

Affimed Presents Additional Data on Combination of AFM13 with Checkpoint Inhibitors at ASH

December 6, 2015

Affimed Presents Data Comparing T-cell- and NK-cell- engaging TandAbs AFM11 and AFM12 at ASH

December 6, 2015

Affimed Announces Appointment of Andrew Curtis to Lead Corporate Strategy and Business Development, Expansion of US Presence

December 2, 2015

Affimed to Present at the Oppenheimer 26th Annual Healthcare Conference –New York

December 1, 2015

Affimed CEO to Present at the Jefferies 2015 Global Healthcare Conference – London

November 11, 2015

Affimed Reports Financial Results for Third Quarter 2015

November 10, 2015

Affimed Presents Data on Potency of NK- and T-cell EGFRvIII TandAbs at SITC

November 6, 2015

Events

All

Scientific

Investors

15Jun

2021 Annual General Meeting

June 15, 2021 (Virtual)

29Jun

Cell Engager Summit

June 29 - July 1, 2021 (virtual)
Presenter: Joachim Koch

Webcasts
More events